Brian K. Halak, 10% Owner at Orexigen Therapeutics, Inc. (OREX), bought 400,000 shares at $6.93 ($2.8M) on 2009-11-23, disclosed to the SEC on 2009-11-24.
Open-market purchase of $2.8M OREX by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.93 | 4,192 | $29K | 1.0% |
| 2 | $6.93 | 245,808 | $1.7M | 61.5% |
| 3 | $6.93 | 2,516 | $17K | 0.6% |
| 4 | $6.93 | 147,484 | $1.0M | 36.9% |
| Total | $6.93 avg | 400,000 | $2.8M | 100% |
| Filing → |
| DRNA | SELL | 2018-11-01 | $2.5M | — | Filing → |
| EVOK | SELL | 2015-08-20 | $1K | — | Filing → |
| ATRA | BUY | 2014-10-21 | $20K | — | Filing → |